BioAtla (BCAB) Other Working Capital Changes (2021 - 2026)
BioAtla's (BCAB) quarterly Other Working Capital Changes came in at $116000.0 in Q1 2026, up 514.29% year-on-year from $18883.7 in Q1 2025, and down 51.26% quarter-over-quarter from $238000.0 in Q4 2025.
BioAtla (BCAB) Other Working Capital Changes (2021 - 2026) Analysis & Trends
BioAtla's Other Working Capital Changes history runs 6 years deep, the most recent figure standing at $116000.0 for Q1 2026.
- On a quarterly basis, Other Working Capital Changes rose 514.29% year-over-year to $116000.0 in Q1 2026; TTM through Mar 2026 was $488000.0, a 230.83% increase from a year earlier, with the FY2025 full-year figure at $344000.0, up 153.67% from the prior year.
- Other Working Capital Changes declined to $116000.0 in Q1 2026 per BCAB's latest filing, from $238000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $3.0 million in Q1 2025 and bottomed at -$2.6 million in Q2 2025.
- The 5-year median for Other Working Capital Changes is -$385000.0 (2023), against an average of -$68941.2.
- Across the five-year window, Other Working Capital Changes sank 1144.44% in 2025 and soared 514.29% in 2026, its largest moves.
- Year by year, Other Working Capital Changes stood at -$140000.0 in 2022, then decreased by 7.14% to -$150000.0 in 2023, then slipped by 9.33% to -$164000.0 in 2024, then soared by 245.12% to $238000.0 in 2025, then slumped by 51.26% to $116000.0 in 2026.
- Per Business Quant, the three latest BCAB Other Working Capital Changes figures stand at $116000.0 (Q1 2026), $238000.0 (Q4 2025), and $358000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,921.77 Bn | 66,921.49 Bn | - |
| 2 | Nanobiotix | 1,933.35 Bn | 1,933.29 Bn | - |
| 3 | Akari Therapeutics | 1,063.56 Bn | 1,063.56 Bn | - |
| 4 | BeOne Medicines | 468.54 Bn | 463.75 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 123.45 Bn | 116.20 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.42 Bn | 61.67 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.57 Bn | 63.57 Bn | - |
| 8 | Argenx Se | 55.83 Bn | 50.65 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.75 Bn | 34.74 Bn | 959.66 Mn |
| 10 | BioAtla | 5.20 Mn | 5.20 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 116,000.00 |
| Mar 31, 2026 | 116,000.00 |
| Mar 31, 2026 | 116,000.00 |
| Dec 31, 2025 | 238,000.00 |
| Dec 31, 2025 | 238,000.00 |
| Dec 31, 2025 | 238,000.00 |
| Sep 30, 2025 | 358,000.00 |
| Sep 30, 2025 | 358,000.00 |
| Sep 30, 2025 | 358,000.00 |
| Jun 30, 2025 | -224,000.00 |
| Jun 30, 2025 | -224,000.00 |
| Jun 30, 2025 | -224,000.00 |
| Mar 31, 2025 | -28,000.00 |
| Mar 31, 2025 | -28,000.00 |
| Mar 31, 2025 | -28,000.00 |
| Dec 31, 2024 | -164,000.00 |
| Dec 31, 2024 | -164,000.00 |
| Dec 31, 2024 | -164,000.00 |
| Sep 30, 2024 | -163,000.00 |
| Sep 30, 2024 | -163,000.00 |